v3.26.1
Stockholders’ Equity (Details Narrative)
 3 Months Ended
Jan. 15, 2025
shares
Dec. 28, 2022
USD ($)
shares
Mar. 28, 2026
USD ($)
shares
Jun. 28, 2025
shares
Mar. 29, 2025
USD ($)
shares
Dec. 27, 2025
shares
Nov. 04, 2020
shares
Nov. 03, 2020
shares
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Common stock, shares authorized     2,000,000,000     2,000,000,000    
Common stock, shares outstanding     127,166,254     126,474,169    
Common stock issued in lieu of professional services 15,499              
Common stock, shares issued     127,166,254     126,474,169    
Options outstanding     20,000,000     20,000,000    
Stock options granted     0          
Series I Convertible Preferred Stock [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Preferred stock, conversion ratio     100          
Conversion of stock, shares converted     4,500          
Preferred stock, outstanding shares     12,500     17,000    
Series Q Convertible Preferred Stock [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Preferred stock, conversion ratio     1          
Conversion of stock, shares converted     57,825   0      
Preferred stock, outstanding shares     867,387     925,212    
Series S Convertible Preferred Stock [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Conversion of stock, shares converted     0          
Preferred stock, outstanding shares     100,000     100,000    
Series S Convertible Preferred Stock [Member] | Soin Therapeutics LLC [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Preferred stock, conversion ratio   1            
Transaction amount | $   $ 30,000,000            
Business acquisition, convertible preferred stock   100,000            
Series V Convertible Preferred Stock [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Preferred stock, conversion ratio     120          
Preferred stock, outstanding shares     0     5,000    
Conversion of stock, shares issued     600,000          
Share Based Payment Arrangement Option [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Share based payment arrangement, expense | $     $ 0          
A 2024 Equity Incentive Plan [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Options authorized for issuance     2,800,000          
A 2023 Equity Incentive Plan [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Options authorized for issuance     2,000,000          
A 2023 Equity Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Share based payment arrangement, expense | $     $ 0   $ 345,000      
Vesting shares issued     908,852          
Plan 2016 [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Options authorized for issuance             800,000 400,000
Options outstanding     100,000     100,000    
Plan 2011 [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Options outstanding     8,000     8,000    
Non Convertible Debenture Small Debenture [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Common stock issued for warrants exercised       45,455 45,455      
Common Stock [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Issuance of shares     160,562          
Common stock issued in lieu of professional services     6,000   15,499      
Common Stock [Member] | ICG Note [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Issuance of shares     17,698          
Articles of Incorporation [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Common stock, shares authorized     2,000,000,000.0          
Common stock, shares outstanding     6,000   15,499